-
Cy7 NHS ester: Practical NIR Labeling Guide
2026-09-12
Cy7 NHS ester (SKU A8109) is a water-soluble, amino-reactive near-infrared dye for labeling proteins, peptides, and other biomolecules with accessible primary amines. It is suited to aqueous conjugation and near-infrared imaging, but it should not be used for targets lacking suitable amines or for workflows requiring long-term storage of prepared dye solutions.
-
From GTP Integrity to Localized p21 mRNA Therapy
2026-09-11
A translational framework connecting Guanosine-5'-triphosphate quality, in vitro transcription, mRNA-LNP development, and localized p21 replacement therapy for bladder cancer.
-
Fra2/LCN2 Drives PM2.5-Aggravated Asthma
2026-09-11
The reference study identifies a Fra2/LCN2 signaling axis that links PM2.5 exposure to mitophagy dysfunction, M2 macrophage ferroptosis, and aggravated asthma. Its combination of multi-omics, chromatin validation, ultrastructural analysis, and macrophage-specific LCN2 knockdown provides a mechanistic framework for studying pollution-associated airway inflammation and intracellular iron dysregulation.
-
Perospirone (SM-9018 freebase) Assay Guide
2026-09-10
This scenario-driven guide explains how Perospirone (SM-9018 freebase), SKU BA5009, can be handled in cell viability, proliferation, receptor-signaling, and vascular ion-channel workflows. It connects product specifications with published Kv-channel evidence to support better controls, concentration design, interpretation, and vendor selection.
-
UAV Spray Drift: Rhodamine B Tracer Evidence
2026-09-10
This field study directly compared pesticide spray drift from an unmanned aerial vehicle sprayer with a traditional electric knapsack sprayer using Rhodamine B as a tracer. It found that UAV application produced wider drift and higher average deposition, providing useful baseline evidence for operational controls and regulatory assessment.
-
H2S Deficiency and ER Stress in Diabetic Cardiomyopathy
2026-09-09
The reference study identifies reduced endogenous hydrogen sulfide production as a mechanistically relevant feature of lipotoxic injury in diabetic cardiomyopathy. Using patient samples, diabetic rats, and palmitate-treated cardiomyocytes, it links H2S deficiency with endoplasmic reticulum stress and shows that H2S donation or ER-stress inhibition reduces myocardial injury.
-
Trypsin-Responsive Nanomedicine for Acute Pancreatitis
2026-09-09
The ACS Nano study developed a trypsin-cleavable organosilica nanoparticle that targets injured pancreatic acinar cells and releases BAPTA-AM in response to disease-associated protease activity. Its combination of acinar-cell targeting, intracellular calcium control, and protease-triggered release improved biochemical, inflammatory, and survival outcomes in a mouse model of acute pancreatitis.
-
(-)-Arctigenin in EV–NF-κB Breast Cancer Models
2026-09-08
(-)-Arctigenin offers a pharmacological way to interrogate inflammatory signaling in macrophage extracellular-vesicle models of breast cancer metastasis. This article distinguishes direct mechanism from assay inference and translates the miR-660–KLHL21–NF-κB axis into a rigorous experimental framework.
-
Sodium Overload, Mitochondrial Failure, and NECSO
2026-09-08
Qiao et al. identify a mechanistic link between TRPM4-mediated sodium influx and necrosis by sodium overload, showing that mitochondrial sodium accumulation disrupts calcium handling, oxidative phosphorylation, and the TCA cycle. The findings position mitochondrial energy failure and Na/K-ATPase collapse as central events in NECSO and provide a framework for studying sodium-driven cell injury.
-
Radicicol Workflows for Hsp90 Inhibition
2026-09-07
Radicicol is a versatile Hsp90 inhibitor for separating adipocyte differentiation, ovarian carcinoma apoptosis, kinase biology, and inflammatory phenotypes in controlled experiments. This guide converts its biochemical profile into practical assay workflows, dose-selection logic, and troubleshooting steps while clearly distinguishing validated product data from optimization recommendations.
-
Radicicol Hsp90 Inhibitor: Applied Research Workflows
2026-09-07
Radicicol supports mechanism-focused studies spanning Hsp90 inhibition, adipocyte differentiation, ovarian carcinoma apoptosis, and inflammatory signaling. This practical guide connects concentration-aware assay design with the Dlat-Trpv3 thermogenesis findings while clearly separating validated product use from exploratory cross-domain applications.
-
AmpC/AmpD Resistance to Ceftolozane-Tazobactam
2026-09-05
Deroche et al. combined targeted mutant construction, sequential time-kill experiments, and semi-mechanistic PKPD modeling to quantify how AmpC G183D and AmpD H157Y mutations drive ceftolozane-tazobactam resistance in Pseudomonas aeruginosa. The study separates baseline susceptibility changes from time-dependent adaptive resistance, offering a more informative framework than MIC measurements alone for interpreting treatment-emergent resistance.
-
EZ Cap™ Firefly Luciferase mRNA Workflow Guide
2026-09-04
Build more reproducible translation, delivery, and bioluminescence assays with a Cap1- and poly(A)-optimized reporter transcript. This guide connects practical handling of EZ Cap™ Firefly Luciferase mRNA with LNP stability insights, in vitro troubleshooting, and in vivo imaging decisions.
-
Dacarbazine Workflows for Cancer Research
2026-09-04
Build more informative Dacarbazine studies by pairing dose–response assays with time-resolved DNA-damage and recovery measurements. This practical guide covers solution preparation, model selection, combination testing, and troubleshooting across melanoma, lymphoma, and sarcoma research.
-
EZ Cap™ Firefly Luciferase mRNA: Assay Design
2026-09-03
Discover how EZ Cap™ Firefly Luciferase mRNA can function not only as a reporter, but also as a diagnostic tool for separating delivery, translation, and cell-state effects. This article connects Cap1 chemistry with recent ionizable-lipid research to improve assay interpretation.